

GAP-134 hydrochloride
CAS No. 943133-81-1
GAP-134 hydrochloride( Danegaptide Hydrochloride | ZP1609 Hydrochloride | GAP134 Hydrochloride | GAP 134 Hydrochloride )
Catalog No. M16752 CAS No. 943133-81-1
A potent, orally active gap-junction modifier; prevents significantly conduction velocity slowing at 10 nM compared with vehicle.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 59 | Get Quote |
![]() ![]() |
5MG | 102 | Get Quote |
![]() ![]() |
10MG | 160 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGAP-134 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, orally active gap-junction modifier; prevents significantly conduction velocity slowing at 10 nM compared with vehicle.
-
DescriptionA potent, orally active gap-junction modifier; prevents significantly conduction velocity slowing at 10 nM compared with vehicle; has highly desirable in vitro and in vivo safety profile including (1) lack of direct effects on membrane ion currents, hERG inhibition, and CYP450 liabilities, (2) negative AMES result, (3) a benign NovaScreen profile, and (4) no effects on systemic hemodynamics.Heart Arrhythmia Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsDanegaptide Hydrochloride | ZP1609 Hydrochloride | GAP134 Hydrochloride | GAP 134 Hydrochloride
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetGap Junction Protein
-
RecptorGap Junction Protein
-
Research AreaCardiovascular Disease
-
IndicationHeart Arrhythmia
Chemical Information
-
CAS Number943133-81-1
-
Formula Weight327.7634
-
Molecular FormulaC14H18ClN3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1C(CN(C1C(=O)O)C(=O)CN)NC(=O)C2=CC=CC=C2.Cl
-
Chemical NameL-Proline, glycyl-4-(benzoylamino)-, hydrochloride (1:1), (4R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Butera JA, et al. J Med Chem. 2009 Feb 26;52(4):908-11.
2. Rossman EI, et al. J Pharmacol Exp Ther. 2009 Jun;329(3):1127-33.
3. Hennan JK, et al. J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):207-14.
molnova catalog



related products
-
GAP-134
A potent, orally active gap-junction modifier; prevents significantly conduction velocity slowing at 10 nM compared with vehicle.
-
Gap 26
Gap 26 is a mimetic peptide corresponding to the residues 63-75 of connexin 43 which is a gap junction blocker.
-
GAP-134 hydrochlorid...
A potent, orally active gap-junction modifier; prevents significantly conduction velocity slowing at 10 nM compared with vehicle.